Role of Atypical MAPK p38 Signaling in the Progression of Influenza A‐Induced Acute Lung Injury
The FASEB Journal · 2025
DOI: 10.1096/fj.202501156rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Jeremy C Burton und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia, USA. Hauptthemen laut MEDLINE: Acute Lung Injury, p38 Mitogen-Activated Protein Kinases, Orthomyxoviridae Infections, Influenza A virus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Mitogen‐activated protein kinase (MAPK) p38 plays a key role in driving the pathology of acute lung injury (ALI), but effective therapeutic targeting remains elusive. Atypical p38 signaling, mediated by interaction with the adaptor protein Tumor Growth Factor β Activated Kinase 1 (TAK1) Binding Protein 1 (TAB1), has so far only been observed during pathological responses, representing a selective and alternative target during pulmonary injury. However, atypical signaling has not been investigated in the context of pulmonary injury and immune responses related to the onset and progression of ALI. Here, we utilized a genetic knock‐in mouse to block influenza A‐induced lung injury mediated by atypical signaling. We report that the loss of TAB1‐p38 interaction reduces weight loss and recovery time, reduces histopathological scores associated with influenza‐induced lung injury early during infection, and prompts earlier recruitment of monocytes to the lungs following infection. These results were found to be independent of viral replication and infectivity, representing the first evidence for the roles of atypical signaling as a driver of host‐mediated pulmonary injury following influenza infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia, USA.
- Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA.
- Department of Clinical and Administrative Pharmacy, College of Pharmacy, University of Georgia, Augusta, Georgia, USA.
- Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA.
ORCID-Profile: Duo Zhang, Neil J Grimsey
Förderung
- NIAID NIH HHS
- HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Burton, J. C., Fahey, D. L., Royer, F. T., Zhu, Y., Sakamoto, K., Zhang, D., Watford, W. T., & Grimsey, N. J. (2025). Role of Atypical MAPK p38 Signaling in the Progression of Influenza A‐Induced Acute Lung Injury. The FASEB Journal. https://doi.org/10.1096/fj.202501156rr
Vancouver
Burton JC, Fahey DL, Royer FT, Zhu Y, Sakamoto K, Zhang D, et al. Role of Atypical MAPK p38 Signaling in the Progression of Influenza A‐Induced Acute Lung Injury. The FASEB Journal. 2025. doi:10.1096/fj.202501156rr
BibTeX
@article{Burton2025,
author = {Burton, Jeremy C and Fahey, Denise L and Royer, Fredejah T and Zhu, Yin and Sakamoto, Kaori and Zhang, Duo and Watford, Wendy T and Grimsey, Neil J},
title = {Role of Atypical MAPK p38 Signaling in the Progression of Influenza A‐Induced Acute Lung Injury},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202501156rr}
}
EUVIMED